Literature DB >> 3652522

Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy.

J J Ballet1, G Sulcebe, L J Couderc, F Danon, C Rabian, M Lathrop, J P Clauvel, M Seligmann.   

Abstract

Pre- and post-immunization serum antibodies to pneumococcal polysaccharides (PPS) and tetanus toxoid (TT) were measured in 25 patients with persistent generalized lymphadenopathy and serum antibodies to the human immunodeficiency virus (HIV). The increase in post-immunization anti-PPS antibodies was lower than 40% in 16/25 patients. Isotype analysis indicated that the IgM, IgA, IgG2, but not the IgG1 antibody responses were lower in patients that in healthy controls, whereas pre-immunization values were similar. For TT, no difference was found between the patients and the healthy group in total and IgG1 antibody response whereas IgG4 response was lower in patients. No significant association was found between the defect in anti-PPS antibody response and associated thrush or constitutional symptoms or other immunological parameters. These findings suggest that defective response to a thymo-independent polysaccharide antigen is a distinctive consequence of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3652522      PMCID: PMC1542747     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Immunoglobulin subclass distribution of human anti-carbohydrate antibodies: aberrant pattern in IgA-deficient donors.

Authors:  L Hammarström; M A Persson; C I Smith
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

2.  Enzyme-linked immunosorbent assay for subclass distribution of human IgG and IgA antigen-specific antibodies.

Authors:  M A Persson; L Hammarström; C I Smith
Journal:  J Immunol Methods       Date:  1985-04-08       Impact factor: 2.303

Review 3.  AIDS--an immunologic reevaluation.

Authors:  M Seligmann; L Chess; J L Fahey; A S Fauci; P J Lachmann; J L'Age-Stehr; J Ngu; A J Pinching; F S Rosen; T J Spira
Journal:  N Engl J Med       Date:  1984-11-15       Impact factor: 91.245

Review 4.  Acquired immune deficiency syndrome in childhood.

Authors:  K M Shannon; A J Ammann
Journal:  J Pediatr       Date:  1985-02       Impact factor: 4.406

5.  Defective B-lymphocyte function in homosexual men in relation to the acquired immunodeficiency syndrome.

Authors:  S G Pahwa; M T Quilop; M Lange; R N Pahwa; M H Grieco
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

6.  Measurement of serum IgG4 levels by a competitive immunoenzymatic assay with monoclonal antibodies.

Authors:  P Aucouturier; F Danon; M Daveau; B Guillou; A Sabbah; J Besson; J L Preud'homme
Journal:  J Immunol Methods       Date:  1984-11-16       Impact factor: 2.303

7.  [Exploration of delayed hypersensitivity with 2,4 dinitrochlorobenzene (DNCB)].

Authors:  J M Dupuy; J L Preud'Homme
Journal:  Presse Med       Date:  1968-01-20       Impact factor: 1.228

8.  Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure.

Authors:  M S Simberkoff; W El Sadr; G Schiffman; J J Rahal
Journal:  Am Rev Respir Dis       Date:  1984-12

9.  An immunohistological approach to persistent lymphadenopathy and its relevance to AIDS.

Authors:  G Janossy; A J Pinching; M Bofill; J Weber; J E McLaughlin; M Ornstein; K Ivory; J R Harris; M Favrot; D C Macdonald-Burns
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

10.  The percentages of six immunoglobulin isotypes in human antibodies to tetanus toxoid: standardization of isotype-specific second antibodies in solid-phase assay.

Authors:  I J Seppälä; N Routonen; A Sarnesto; P A Mattila; O Mäkelä
Journal:  Eur J Immunol       Date:  1984-09       Impact factor: 5.532

View more
  34 in total

1.  Immunoglobulin G (IgG) subclass distribution and IgG1 avidity of antibodies in human immunodeficiency virus-infected individuals after revaccination with tetanus toxoid.

Authors:  F P Kroon; M J van Tol; C M Jol-van der Zijde; R van Furth; J T van Dissel
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

Review 2.  The second century of the antibody. Molecular perspectives in regulation, pathophysiology, and therapeutic applications.

Authors:  J Braun; A Saxon; R Wall; S L Morrison
Journal:  West J Med       Date:  1992-08

3.  Immunoglobulin V(H) usage during primary infection of rhesus monkeys with chimeric simian-human immunodeficiency viruses.

Authors:  D H Margolin; K A Reimann; J Sodroski; G B Karlsson; K Tenner-Racz; P Racz; N L Letvin
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 4.  Antibody responses in HIV infection.

Authors:  A J Pinching
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

5.  Competition within the virus-specific CD4 T-cell pool limits the T follicular helper response after influenza infection.

Authors:  Matthew R Olson; Brendon Y Chua; Kim L Good-Jacobson; Peter C Doherty; David C Jackson; Stephen J Turner
Journal:  Immunol Cell Biol       Date:  2016-04-22       Impact factor: 5.126

6.  Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals.

Authors:  Susan Moir; Kisani M Ogwaro; Angela Malaspina; Joshua Vasquez; Eileen T Donoghue; Claire W Hallahan; Shuying Liu; Linda A Ehler; Marie A Planta; Shyamasundaran Kottilil; Tae-Wook Chun; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-01       Impact factor: 11.205

Review 7.  The molecular structure of human antibodies specific for the human immunodeficiency virus.

Authors:  J S Andris; J D Capra
Journal:  J Clin Immunol       Date:  1995-01       Impact factor: 8.317

8.  Association of phenotypic changes in B cell lymphocytes and plasma viral load in human immunodeficiency virus-infected patients.

Authors:  M R Dawood; B Conway; P Patenaude; F Janmohamed; J S Montaner; M V O'Shaughnessy; G W Hammond
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

9.  Urinary tract infection in men with AIDS.

Authors:  A M De Pinho; G S Lopes; C F Ramos-Filho; O da R Santos; M P De Oliveira; M Halpern; C A Gouvea; M Schechter
Journal:  Genitourin Med       Date:  1994-02

10.  Noninfectious X4 but not R5 human immunodeficiency virus type 1 virions inhibit humoral immune responses in human lymphoid tissue ex vivo.

Authors:  Wendy Fitzgerald; Andrew W Sylwester; Jean-Charles Grivel; Jeffrey D Lifson; Leonid B Margolis
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.